Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antagonism of cysteinyl leukotrienes and their receptors as a neuroinflammatory target in Alzheimer’s disease
Rakesh Kumar Singh
Neurological Sciences (2020) Vol. 41, Iss. 8, pp. 2081-2093
Closed Access | Times Cited: 13

Showing 13 citing articles:

Arachidonic Acid Derivatives and Neuroinflammation
Era Gorica, Vincenzo Calderone
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 2, pp. 118-129
Closed Access | Times Cited: 30
A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities
Siva Prasad Panda, Urvashi Soni
Ageing Research Reviews (2022) Vol. 75, pp. 101560-101560
Closed Access | Times Cited: 19
Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19
Mangaldeep Dey, Rakesh Kumar Singh
Pharmacology (2021) Vol. 106, Iss. 9-10, pp. 469-476
Open Access | Times Cited: 14
Exposure of aluminium to C6 glioma cells modulates molecular and functional neurotoxic markers
Mangaldeep Dey, Rakesh Kumar Singh
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 8
Bioactive lipids and their metabolism: New therapeutic opportunities for Parkinson's disease
Wenjing Shen, Li Jiang, Jingyi Zhao, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 3, pp. 846-872
Closed Access | Times Cited: 10
Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Insights into the advances in therapeutic drugs for neuroinflammation-related diseases
B. Luo
International Journal of Neuroscience (2023), pp. 1-26
Closed Access | Times Cited: 3
Natural products from selected medicinal plants as potential therapeutics in Alzheimer's disease
Parvathy G. Nair, Amit Kumar Dixit, Deepti Dixit, et al.
Studies in natural products chemistry (2024), pp. 79-113
Closed Access
Emerging role of cysteinyl leukotrienes in cancer
Lou Saier, Olivier Peyruchaud
Authorea (Authorea) (2020)
Open Access | Times Cited: 2
Introduction
Fatma Tuğçe Gürağaç Dereli, Tarun Belwal
Elsevier eBooks (2020), pp. 1-10
Closed Access
Matricaria recutita
Fatma Tuğçe Gürağaç Dereli, Tarun Belwal
Elsevier eBooks (2020), pp. 293-300
Closed Access
Neuroprotection of Multitargeted Phytochemicals against Alzheimer: A Desperate Need from Nature
Ashwani K. Dhingra, Bhawna Chopra
The Natural Products Journal (2022) Vol. 13, Iss. 5
Closed Access
Anti-leukotriene drugs in the therapy of inflammatory diseases
Bartłomiej Pyrak, Karolina Rogacka, Dariusz Maciej Pisklak
Prospects in Pharmaceutical Sciences (2022) Vol. 20, Iss. 2, pp. 1-23
Open Access
Page 1

Scroll to top